A promising solution to enhance the sensocompatibility of biosensors in continuous glucose monitoring systems

Journal of Diabetes Science and Technology

Volumn 7, Issue 2, 2013, Pages 455-464

  Van Den Bosch, Edith E M ^a   De Bont, Nik H M ^a   Qiu, Jun ^a   Gelling, Onko Jan ^a  

^a DSM Biomedical   (Netherlands)

Author keywords

Biocompatibility; Biofouling; Coating; Continuous glucose monitoring; Glucose sensor

Indexed keywords

BOVINE SERUM ALBUMIN; CELLULOSE ACETATE; FIBRIN; GLUCOSE; LYSOZYME; MACROGOL; OXYGEN; ARTIFICIAL MEMBRANE; BIOMATERIAL; CELLULOSE; GLUCOSE BLOOD LEVEL; MACROGOL DERIVATIVE; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; CYTOTOXICITY; FILTER; GLUCOSE SENSOR; HEMADSORPTION; HEMOLYSIS; HYDROPHILICITY; MEMBRANE FILTER; OXYGEN DIFFUSION; PAPER; PERMEABILITY; POROSITY; SENSITIZATION; THICKNESS; THROMBOCYTE; ANALOGS AND DERIVATIVES; ANALYSIS; ARTIFICIAL MEMBRANE; BIOMECHANICS; CHEMICAL PHENOMENA; CHEMISTRY; DEVICES; DIAGNOSTIC USE; EXTRACELLULAR FLUID; GENETIC PROCEDURES; GLUCOSE BLOOD LEVEL; HUMAN; MATERIALS TESTING; METABOLISM; PHYSIOLOGIC MONITORING; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SUBCUTANEOUS TISSUE; SYNTHESIS; EQUIPMENT; METHODOLOGY;

ADSORPTION; BIOMECHANICAL PHENOMENA; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; CELLULOSE; COATED MATERIALS, BIOCOMPATIBLE; EXTRACELLULAR FLUID; GLUCOSE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; MONITORING, PHYSIOLOGIC; OXYGEN; POLYETHYLENE GLYCOLS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN, BOVINE; SUBCUTANEOUS TISSUE;

EID: 84891399253     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700223     Document Type: Article

References (34)

1. Halimi S. Acute consequences of hypoglycaemia in diabetic patients. Diabetes Metab. 2010;36 Suppl 3:S75-83.
2. Bonds DE, Miller ME, Dudl J, Feinglos M, Ismail-Beigi F, Malozowski S, Seaquist E, Simmons DL, Sood A. Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: secondary analysis of the ACCORD clinical trial data. BMC Endocr Disord. 2012;12:5.
3. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: metaanalysis of randomised controlled trials. BMJ. 2011;343:d4169.
4. Wentholt IM, Vollebregt MA, Hart AA, Hoekstra JB, DeVries JH. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. Diabetes Care. 2005;28(12):2871-6. (Pubitemid 43942917)
5. Wickramasinghe Y, Yang Y, Spencer SA. Current problems and potential techniques in in vivo glucose monitoring. J Fluoresc. 2004;14(5):513-20.
6. Abel PU, von Woedtke T. Biosensors for in vivo glucose measurement: can we cross the experimental stage. Biosens Bioelectron. 2002;17(11-12):1059-70. (Pubitemid 35232479)
7. Heinemann L, Koschinsky T. Continuous glucose monitoring: an overview of today's technologies and their clinical applications. Int J Clin Pract Suppl. 2002;129:75-9.
8. Sieg A, Guy RH, Delgado-Charro MB. Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabetes Technol Ther. 2005;7(1):174-97. (Pubitemid 40354587)
9. Pickup J, Rolinski O, Birch D. In vivo glucose sensing for diabetes management: progress towards non-invasive monitoring. Interview by Judy Jones. BMJ. 1999;319(7220):1289.
10. Wilson GS, Giford R. Biosensors for real-time in vivo measurements. Biosens Bioelectron. 2005;20(12):2388-403. (Pubitemid 40602179)
11. Cardosi MF, Birch SW. Screen printed glucose electrodes based on platinised carbon particles and glucose oxidase. Anal Chim Acta. 1993;276:69-74. (Pubitemid 23094266)
12. Mizutani F, Yabuki S, Iijima S. Carbon paste electrode incorporated with cobalt(II) octaethoxyphthalocyanine for the amperometric detection of hydrogen peroxide. Electroanalysis. 1995;7(8):706-9.
13. Fischer U. Continuous in vivo monitoring in diabetes: the subcutaneous glucose concentration. Acta Anaesthesiol Scand Suppl. 1995;104:21-9.
14. Fischer U, Ertle R, Abel P, Rebrin K, Brunstein E, Hahn von Dorsche H, Freyse EJ. Assessment of subcutaneous glucose concentration: validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs. Diabetologia. 1987;30(12):940-5. (Pubitemid 18055852)
15. Pickup JC, Shaw GW, Claremont DJ. In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer. Diabetologia. 1989;32(3):213-7. (Pubitemid 19117104)
16. Moussy F, Harrison DJ, Rajotte RV. A miniaturized Nafion-based glucose sensor: in vitro and in vivo evaluation in dogs. Int J Artif Organs. 1994;17(2):88-94. (Pubitemid 24133674)
17. Claremont DJ, Sambrook IE, Penton C, Pickup JC. Subcutaneous implantation of a ferrocene-mediated glucose sensor in pigs. Diabetologia. 1986;29(11):817-21. (Pubitemid 17053721)
18. Steil GM, Rebrin K, Mastrototaro J, Bernaba B, Saad MF. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther. 2003;5(1):27-31. (Pubitemid 36506087)
19. Rebrin K, Fischer U, Hahn von Dorsche H, von Woetke T, Abel P, Brunstein E. Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality. J Biomed Eng. 1992;14(1):33-40.
20. Cote GL, Lec RM, Pishko MV. Emerging biomedical sensing technologies and their applications. IEEE Sens J. 2003;3(3):251-66.
21. Pickup JC. In vivo glucose monitoring: sense and sensorbility. Diabetes Care. 1993;16(2):535-9. (Pubitemid 23046648)
22. Pfeifer EF. On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985. Diabetologia. 1987;30(2):51-65.
23. Valdes TI, Moussy F. In vitro and in vivo degradation of glucose oxidase enzyme used for an implantable glucose biosensor. Diabetes Technol Ther. 2000;2(3):367-76.
24. Kvist PH, Iburg T, Bielecki M, Gerstenberg M, Buch-Rasmussen T, Hasselager E, Jensen HE. Biocompatibility of electrochemical glucose sensors implanted in the subcutis of pigs. Diabetes Technol Ther. 2006;8(4):463-75. (Pubitemid 44735466)
25. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med. 1993;178(6):2147-56. (Pubitemid 23344872)
26. Maitra M, Abbas AK. The endocrine system. In: Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran pathologic basis of disease. Philadelphia: Elsevier Saunders; 2005, 1189-205.
27. Wang YX, Robertson JL, Spillman WB Jr, Claus RO. Effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility. Pharm Res. 2004;21(8):1362-73. (Pubitemid 39149650)
28. Kvist PH, Jensen HE. Recent advances in continuous glucose monitoring: biocompatibility of glucose sensors for implantation in subcutis. J Diabetes Sci Technol. 2007;1(5):746-52.
29. Tang L, Eaton JW. Inflammatory responses to biomaterials. Am J Clin Pathol. 1995;103(4):466-71.
30. Klueh U, Liu Z, Feldman B, Henning TP, Cho B, Ouyang T, Kreutzer D. Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages. J Diabetes Sci Technol. 2011;5(3):583-95.
31. Holmes PF, Currie EP, Thies JC, Van der Mei HC, Busscher HJ, Norde W. Surface-modified nanoparticles as a new, versatile, and mechanically robust nonadhesive coating: Suppression of protein adsorption and bacterial adhesion. J Biomed Mater Res A. 2009;91(3):824-33.
32. Dijt JC, Stuart MA, Hofman JE, Fleer GJ. Kinetics of polymer adsorption in stagnation point flow. Coll Surf. 1990;51:141-58.
33. Tan Q, Ji J, Barbosa MA, Fonseca C, Shen J. Constructing thromboresistant surface on biomedical stainless steel via layer-by-layer deposition anticoagulant. Biomaterials. 2003;24(25):4699-705. (Pubitemid 37013631)
34. Van Oeveren W, Tielliu IF, de Hart J. Comparison of modified Chandler, roller pump, and ball valve circulation models for in vitro testing in high blood flow conditions: application in thrombogenicity testing of different materials for vascular applications. Int J Biomater. 2012;2012:673163.